Regulatory Support

On a case-by-case basis, the Institute for Regenerative Cures partners with teams of investigators to assist with the development of preIND meetings and IND applications to the U.S. Food and Drug Administration. Institute staff have exceptional skill and experience with both gene-modified and unmodified adult stem cells. Hourly consultation rates are available. 

Contact: William (Bill) Gruenloh   |   wjgruenloh@health.ucdavis.edu